Udvalget konstaterede, at fordelen ved Truvada kun er påvist hos patienter, der ikke tidligere har fået medicin mod hiv, men at den forenklede doseringsplan med en kombinationstablet, der tages én gang dagligt, kan gøre det lette - re for patienterne at overholde behandlingen.
It noted that the benefit of Truvada has only been shown in patients who have not taken HIV treatment before, but that the simplified dosing regimen offered by the combination tablet taken once a day may help patients to stick to their treatment.